Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2010 1
2011 1
2014 2
2015 1
2016 1
2017 1
2018 1
2019 2
2020 3
2021 6
2022 4
2023 1
2024 3
2025 3
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.
Kasikova L, Rakova J, Hensler M, Lanickova T, Tomankova J, Pasulka J, Drozenova J, Mojzisova K, Fialova A, Vosahlikova S, Laco J, Ryska A, Dundr P, Kocian R, Brtnicky T, Skapa P, Capkova L, Kovar M, Prochazka J, Praznovec I, Koblizek V, Taskova A, Tanaka H, Lischke R, Mendez FC, Vachtenheim J Jr, Heinzelmann-Schwarz V, Jacob F, McNeish IA, Halaska MJ, Rob L, Cibula D, Orsulic S, Galluzzi L, Spisek R, Fucikova J. Kasikova L, et al. Among authors: capkova l. Nat Commun. 2024 Mar 21;15(1):2528. doi: 10.1038/s41467-024-46873-w. Nat Commun. 2024. PMID: 38514660 Free PMC article.
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma.
Lanickova T, Angelidou A, Hensler M, Vankerckhoven A, Niederlova V, Vosahlikova S, Kasikova L, Bock A, Zacharova E, Stekas C, Tunkova B, Tomankova J, Glatzova D, Moserova I, Drozenova J, Cveckova B, Shankar T, Laco J, Ryska A, Dundr P, Ndukwe MI, Cibula D, Vachtenheim J Jr, Lischke R, Capkova L, Kovar M, Halaska MJ, Rob L, Allonsius L, Laoui D, Hanns A, Cremer I, Orsulic S, Stepanek O, Jacob F, Galluzzi L, Spisek R, Fucikova J. Lanickova T, et al. Among authors: capkova l. Nat Commun. 2026 Apr 17. doi: 10.1038/s41467-026-72036-0. Online ahead of print. Nat Commun. 2026. PMID: 41998001 Free article.
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease.
Jelinek T, Sevcikova T, Zihala D, Popkova T, Kapustova V, Broskevicova L, Capkova L, Rihova L, Bezdekova R, Sevcikova S, Zidlik V, Havel M, Plonkova H, Jungova A, Minarik J, Stork M, Pour L, Pavlicek P, Spicka I, Maisnar V, Radocha J, Simicek M, Hajek R. Jelinek T, et al. Among authors: capkova l. Leukemia. 2022 Jan;36(1):288-291. doi: 10.1038/s41375-021-01343-w. Epub 2021 Jul 10. Leukemia. 2022. PMID: 34247197 No abstract available.
Biopsy of lung lesions under CT control.
Marel M, Padr R, Fila L, Rakita D, Casas Mendez F, Capkova L, Capek V, Pavlik R. Marel M, et al. Among authors: capkova l. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Nov;165(4):390-394. doi: 10.5507/bp.2020.040. Epub 2020 Sep 17. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021. PMID: 32955039 Free article.
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma.
Hájek R, Minařík J, Straub J, Pour L, Jungova A, Berdeja JG, Boccadoro M, Brozova L, Spencer A, van Rhee F, Vela-Ojeda J, Thompson MA, Abonour R, Chari A, Cook G, Costello CL, Davies FE, Hungria VT, Lee HC, Leleu X, Puig N, Rifkin RM, Terpos E, Usmani SZ, Weisel KC, Zonder JA, Bařinová M, Kuhn M, Šilar J, Čápková L, Galvez K, Lu J, Elliott J, Stull DM, Ren K, Maisnar V. Hájek R, et al. Among authors: capkova l. Future Oncol. 2021 Jul;17(19):2499-2512. doi: 10.2217/fon-2020-1225. Epub 2021 Mar 26. Future Oncol. 2021. PMID: 33769076 Free article.
A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade.
Ozaniak A, Smetanova J, Bartolini R, Rataj M, Capkova L, Hacek J, Fialova M, Krupickova L, Striz I, Lischke R, Bartunkova J, Strizova Z. Ozaniak A, et al. Among authors: capkova l. J Cancer Res Clin Oncol. 2023 Jul;149(7):3789-3801. doi: 10.1007/s00432-022-04292-8. Epub 2022 Aug 20. J Cancer Res Clin Oncol. 2023. PMID: 35986756 Free PMC article.
31 results